Maxipime  l g powder for solution for injection България - български - Изпълнителна агенция по лекарствата

maxipime  l g powder for solution for injection

bristol- myers squibb kft; - Цефепим - l g powder for solution for injection

Critipime 1 g powder for solution for injection/infusion България - български - Изпълнителна агенция по лекарствата

critipime 1 g powder for solution for injection/infusion

sandoz d.d. - Цефепим - 1 g powder for solution for injection/infusion

AlphAcef  l g powder for solution for injection България - български - Изпълнителна агенция по лекарствата

alphacef  l g powder for solution for injection

medochemie ltd. - Цефепим - l g powder for solution for injection

Zavicefta Европейски съюз - български - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - Антибактериални средства за подаване на заявления, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Трябва да се вземат предвид официалните препоръки за правилното използване на антибактериални агенти.

Recarbrio Европейски съюз - български - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - монохидрат Имипенем, циластатин натрий, relebactam монохидрат - Грамотрицательные Бактериални Инфекции - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 и 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 и 5. Трябва да се вземат предвид официалните препоръки за правилното използване на антибактериални агенти.

КОНСТЕЛ® България - български - Adama

КОНСТЕЛ®

adama - Суспензионен концентат (СК) - 25 г/л дифлуфеникан + 400 г/л хлоротолурон - Хербициди